Mark Lunt

24.4k citations
354 papers · 16.1k · 4 hit papers · h-index 70

Impact in

  • Rheumatology top 0.02%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
    • Bone health and osteoporosis research

Papers in

    • Rheumatoid Arthritis Research and Therapies 127
    • Systemic Lupus Erythematosus Research 17
    • Psoriasis: Treatment and Pathogenesis 25
    • Biosimilars and Bioanalytical Methods 15

Mark Lunt

343 papers receiving 15.6k citations

Mark Lunt's Hit Papers

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly 2010 · 502 citations
5020+6+13Years since publication100200300400500

Peers

Mark Lunt
Comparison fields: 5 of 192
  • Rheumatology 6.2k
  • Orthopedics and Sports Medicine 1.2k
  • Hematology 1.5k
  • Immunology 2.6k
  • Pathology and Forensic Medicine 1.1k
Replace Cynthia S. Crowson with:
Cynthia S. Crowson United States
Hilal Maradit Kremers United States
Sherine E. Gabriel United States
Maxime Dougados France
Laure Gossec France
Maarten Boers Netherlands
Maxime Dougados France
Jeffrey R. Curtis United States
Loreto Carmona Spain
Sang‐Cheol Bae South Korea
Mark Lunt relative to Cynthia S. Crowson United States Cynthia S. Crowson's profile →
Citations per field
00.5×1.5×
Cynthia S. Crowson · 1×
Citations per year

Countries citing papers authored by Mark Lunt

Since Specialization
Citations

This map shows the geographic impact of Mark Lunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lunt more than expected).

Fields of papers citing papers by Mark Lunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lunt. The network helps show where Mark Lunt may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Lunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Lunt Line = papers co-authored together Mark Lunt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 354 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
Hit paper breakdown →
2006535
2
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
Hit paper breakdown →
2009532
3
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
Hit paper breakdown →
2010502
4
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
Hit paper breakdown →
2007430
5 2003345
6 2006313
7 2015280
8 2002274
9 2013255
10 2005251
11 2005227
12 2001227
13 2007218
14 2002215
15 2008192
16 1999179
17 2014172
18 2011170
19 2020168
20 2003166

About Mark Lunt

Mark Lunt is a scholar working on Rheumatology, Immunology, Surgery, Orthopedics and Sports Medicine and Hematology, having authored 354 papers that have together received 16.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (127 papers), Psoriasis: Treatment and Pathogenesis (25 papers), Bone health and osteoporosis research (22 papers), Autoimmune and Inflammatory Disorders Research (19 papers), Systemic Lupus Erythematosus Research (17 papers), Biosimilars and Bioanalytical Methods (15 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Advanced Causal Inference Techniques (10 papers). The work is most often cited by research in Rheumatology (6.2k citations), Orthopedics and Sports Medicine (1.2k citations), Hematology (1.5k citations), Immunology (2.6k citations) and Pathology and Forensic Medicine (1.1k citations). Mark Lunt has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Deborah Symmons, Kimme L Hyrich, Alan J. Silman, Kath Watson, William G Dixon, James Galloway, Diane Bunn, Louise Mercer, Andrew Ustianowski and Terence W O’Neill. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, British Journal of Dermatology, Arthritis Care & Research and Osteoporosis International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact